← HEALTHEQUITY, INC.
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $178.4m | $229.5m | $287.2m | $532.0m | $733.6m | $756.6m | $861.7m | $999.6m | $1.2b | $1.3b | |
| Cost of Revenue | $117.0m | $150.0m | $106.0m | $206.1m | $318.2m | $332.9m | $371.7m | $376.9m | $422.5m | $400.3m | |
| Gross Profit | $106.4m | $134.9m | $181.2m | $325.9m | $415.3m | $423.7m | $490.1m | $622.6m | $777.3m | $913.1m | |
| Operating Expenses | $65.1m | $80.5m | $103.5m | $248.9m | $381.3m | $447.9m | $481.0m | $504.9m | $614.9m | $590.7m | |
| Operating Income (Loss) | $41.2m | $54.4m | $77.7m | $77.0m | $34.0m | ($24.2m) | $9.1m | $117.7m | $162.3m | $322.5m | |
| Additional Financial Items | |||||||||||
| Amortization of Intangible Assets | $11.2m | $13.2m | $14.7m | $46.5m | $99.9m | $122.5m | $148.9m | $144.3m | $157.8m | $152.7m | |
| Gain (Loss) on Investments | $0 | — | — | — | — | — | — | — | — | — | |
| Goodwill, Impairment Loss | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Preferred Stock Dividends and Other Adjustments | $0 | — | — | — | — | — | — | — | — | — | |
| Preferred Stock Dividends, Income Statement Impact | $0 | — | — | — | — | — | — | — | — | — | |
| Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | $0 | — | — | — | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $40.1m | $52.2m | $75.8m | $43.2m | $4.1m | ($66.7m) | ($38.1m) | $75.0m | $116.0m | $277.4m | |
| Net Income (Loss) Attributable to Parent | $26.4m | $47.4m | $73.9m | $39.7m | $8.8m | ($44.3m) | ($26.1m) | $55.7m | $96.7m | $215.2m | |
| Net Income (Loss) Available to Common Stockholders, Basic | $26.4m | $47.4m | $73.9m | $39.7m | $8.8m | ($44.3m) | ($26.1m) | $55.7m | $96.7m | $215.2m | |
| Earnings Per Share, Basic | $0.45 | $0.79 | $1.20 | $0.59 | $0.12 | ($0.53) | ($0.31) | $0.65 | $1.11 | $2.50 | |
| Earnings Per Share, Diluted | $0.44 | $0.77 | $1.17 | $0.58 | $0.12 | ($0.53) | ($0.31) | $0.64 | $1.09 | $2.46 | |
| Weighted Average Number of Shares Outstanding, Basic | 58.6m | 60.3m | 61.8m | 67.0m | 74.2m | 83.1m | 84.4m | 85.6m | 86.9m | 86.1m | |
| Weighted Average Number of Shares Outstanding, Diluted | 59.9m | 61.9m | 63.4m | 68.5m | 75.7m | 83.1m | 84.4m | 87.0m | 88.8m | 87.5m | |
| Other Nonoperating Income (Expense) | ($1.1m) | ($2.2m) | ($1.9m) | ($9.1m) | $5.0m | ($5.9m) | $1.3m | $12.8m | $14.3m | $12.1m | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $60.6m | $57.1m | |
| Business Combination, Acquisition Related Costs | — | — | — | $40.8m | $1.1m | $10.8m | $53k | $0 | $0 | — | |
| Current Income Tax Expense (Benefit) | $16.7m | $522k | $1.5m | ($174k) | $439k | $867k | $5.2m | $33.3m | $32.2m | $22.5m | |
| General and Administrative Expense | $20.2m | $25.1m | $33.0m | $60.6m | $84.5m | $84.4m | $95.6m | $103.7m | $132.3m | $119.9m | |
| Interest Expense | — | $274k | $270k | $24.8m | $34.9m | $36.6m | $48.4m | $55.5m | $60.6m | $57.1m | |
| Nonoperating Income (Expense) | — | — | — | ($33.9m) | ($29.9m) | ($42.5m) | ($47.2m) | ($42.7m) | ($46.3m) | ($45.0m) | |
| Operating Lease, Expense | — | — | — | $9.1m | — | — | — | — | — | — | |
| Research and Development Expense | $22.4m | $27.4m | $35.1m | $77.6m | $124.8m | $157.4m | $193.4m | $218.8m | $239.5m | $262.5m | |
| Selling and Marketing Expense | $18.3m | $23.1m | $29.5m | $44.0m | $50.0m | $58.6m | $68.8m | $79.3m | $90.7m | $95.2m | |
| Income Tax Expense (Benefit) | $13.7m | $4.8m | $1.9m | $3.5m | ($4.7m) | ($22.5m) | ($12.0m) | $19.3m | $19.3m | $62.2m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.